CClinicalTrials.gg
RecruitingNCT06528717AGICSUpdated Jul 30, 2024

The Role of Maintaining External Carotid Artery Flow in Graft Interposition After Carotid Endarterectomy

An observational study in Carotid Artery Diseases, Stroke and Carotid Atherosclerosis, sponsored by Institute for Cardiovascular Diseases Dedinje. Recruiting at 1 site in Serbia. Open to participants aged 50 Years to 90 Years. Per ClinicalTrials.gov, last updated 2024-07-30.

Sponsored by Institute for Cardiovascular Diseases Dedinje · Observational

From the registry’s dates

  • Primary completion was expected by Oct 2024, 1 year 11 months ago, but the record still lists the study as recruiting.
  • Started Jun 2024; still recruiting 2 years 3 months later.
Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
250
Ages
50 Years to 90 Years
Sex
All
01

Study summary

Analyzing results of carotid graft interposition with and without flow preservation through external carotid artery after endarterectomy.

Read the detailed description

Surgical and endovascular treatment have been shown as effective treatment modalities in symptomatic and asymptomatic patients at high risk of stroke on medical therapy with significant carotid artery stenosis. Eversion carotid endarterectomy (eCEA) has proven effective as a surgical treatment modality. In highly selected instances carotid bypass may be indicated as a bailout procedure or primarily as a preoperatively planned maneuver. Usually, the decision for substitution of carotid bifurcation with a synthetic graft is made due to an extensive, severe atherosclerotic process on the distal part of the extracranial internal carotid artery, the presence of uncontrollable atherosclerotic plaque after endarterectomy, and in cases when an exceptionally thin artery wall remains after endarterectomy.

Several techniques have been described for substituting carotid bifurcation with a synthetic graft. The most common technique involves complete resection and excision of the carotid bifurcation and reconstruction with graft interposition between the undiseased segment of the common carotid artery (CCA) proximally and the internal carotid artery (ICA) distally by creating proximal and distal end-to-end anastomoses. This technique requires ligation and exclusion of the external carotid (ECA) and the superior thyroid artery from circulation. The less common techniques that preserve flow through the external carotid artery are performed as a primary option for treatment without previous endarterectomy and are seldom applied. Currently, there are no recommendations regarding the administration of carotid bypass, nor comparisons of these techniques.

In this study, the investigators are comparing a technique with graft interposition between endarterectomized CCA (creation of side-to-end anastomosis) and the distal segment of the ICA (end-to-end anastomosis) after failure of eCEA to provide technical success with the described common interposition by end-to-end anastomoses proximally and distally. Therefore, the role of flow preservation through the ECA could be defined.

02

Conditions studied

  • Carotid Artery Diseases
  • Stroke
  • Carotid Atherosclerosis
03

In context

Carotid Artery Diseases

248 studies on the registry are indexed under Carotid Artery Diseases; 56 are open to participants now.

This study's planned enrollment of 250 is above the median of 224 across 108 observational studies indexed under Carotid Artery Diseases.

Browse Carotid Artery Diseases studies →

Lead sponsor

Institute for Cardiovascular Diseases Dedinje is the lead sponsor of 4 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
50 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients who underwent carotid artery surgery due to atherosclerotic symptomatic and asymptomatic disease had graft interposition conducted due to unsuccessful endarterectomy.

Inclusion criteria

  • symptomatic carotid stenosis (> 50%)
  • unilateral asymptomatic carotid stenosis (> 60%)
  • bilateral asymptomatic carotid stenosis (> 60%)

Exclusion criteria

Exclusion Criteria:

  • carotid restenosis
  • "major surgery" in previous 6 months
  • previous brain trauma or surgery
  • malignant disease
  • epilepsy
  • carotid artery aneurysm
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
250 participants (estimated)
Patient registry
No

Groups and cohorts

  • ECA flow preserved group

    Patients with carotid graft interposition after endarterectomy of the common carotid artery and external carotid artery with preserved flow through the external carotid artery by side-to-end proximal anastomosis.

    Procedure: Carotid graft interposition

  • Ligated ECA group

    Patients with carotid graft interposition and end-to-end anastomoses on the undiseased segments of the common (proximally) and internal (distally) carotid artery, with ligation of the external carotid artery.

    Procedure: Carotid graft interposition

Interventions

  • ProcedureCarotid graft interposition

    In patients with extensive atherosclerotic carotid disease, when endarterectomy isn't feasible, replacement of the carotid artery with a graft is needed. Graft interposition can be performed either by end-to-end proximal and distal anastomoses in the undiseased common and internal carotid artery with ligation of the external carotid artery, or by side-to-end proximal anastomosis on the origin of the internal carotid artery and end-to-end distal anastomosis on the internal carotid artery with flow preservation in the external carotid artery.

    Also known as: Carotid artery graft replacement, Carotid replacement with Dacron graft

06

What researchers measure

Primary outcomes

  1. periprocedural stroke and death

    onset of new neurological deficit or death during perioperative period

    Time frame: 30 days

  2. myocardial infarction

    development of new acute coronary events during perioperative period

    Time frame: 30 days

  3. stroke ipsilateral to the procedure

    development of new neurological events that are pathophysiological atributable to the operated side

    Time frame: through study completion, an average of 2 years

Secondary outcomes

  1. restenosis rate

    restenosis after graft placement diagnosed by color Doppler sonographic examination or by multiplanar detection computerized tomography angiography

    Time frame: through study completion, an average of 2 years

  2. graft patency

    primary and primary assisted

    Time frame: through study completion, an average of 2 years

  3. patient survival

    defining cause of death

    Time frame: through study completion, an average of 2 years

07

Study locations

1 of 1 sites recruiting
  • Institute for Cardiovascular Diseases Dedinje
    Belgrade, 11000, Serbia
    Recruiting
08

References and documents

Publications

  • Timaran CH, McKinsey JF, Schneider PA, Littooy F. Reporting standards for carotid interventions from the Society for Vascular Surgery. J Vasc Surg. 2011 Jun;53(6):1679-95. doi: 10.1016/j.jvs.2010.11.122. No abstract available. PubMed 21609800 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 30, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06528717
Lead sponsor
Institute for Cardiovascular Diseases Dedinje
Responsible party
Slobodan Pesic (MD, Institute for Cardiovascular Diseases Dedinje) — Principal investigator
First posted
Jul 30, 2024
Start date
Jun 12, 2024
Primary completion
Oct 30, 2024 (estimated)
Completion
Dec 30, 2024 (estimated)
Last update
Jul 30, 2024

Study contacts

Slobodan Pesic, MD
Contact
spesic90@gmail.com
00381616303360
Jovan Petrovic, MD
Contact
jovanpetrovic1997@gmail.com
Srdjan Babic, MD PhD
study director · Institute for Cardiovascular Diseases Dedinje

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion